Iovance Biotherapeutics, Inc. (IOVA) short interest & options flow
NASDAQIovance Biotherapeutics heads into its November 6 earnings print with the short book still contracting, analyst targets moving sharply higher, and options traders finally starting to hedge. The short unwind has now taken on genuine momentum. Short interest dropped 19% on the week to 15.4% of the free float, or roughly 61 million shares. That is the largest weekly decline since the…
IOVA put call ratio hits 0.58, highest in 52 weeks, as options traders pile into calls ahead of November earnings.
- Market cap
- $3.64B
- Next earnings
- 24 Feb 2027
Key data as of 8 Nov 2026

IOVA news and analysis
RSSNo long-form analysis yet for IOVA. Pulse alerts and the live data picture are available on ORTEX.
Open IOVA on ORTEX →Want the live picture for IOVA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IOVA — free to start on ORTEX.
Sign up for free →Open IOVA on ORTEX